SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lilly’s retatrutide reduced knee osteoarthritis pain in a Phase 3 trial

The Phase 3 trial reported reduced knee osteoarthritis pain with retatrutide.

LLY

Related stories